Age-Related Macular Degeneration

SEATTLE — In this video, Rishi P. Singh, MD, FASRS, discusses presentations from the ASRS annual meeting that discussed high-dose aflibercept for the treatment of neovascular age-related macular degeneration.

SEATTLE — In this video from the ASRS meeting, Rishi P. Singh, MD, FASRS, discusses the results of recent extension studies of pegcetacoplan for the treatment of geographic atrophy.

SEATTLE — The phase 2 AAVIATE study showed safety and efficacy of ABBV-RGX-314 gene therapy in the treatment of neovascular age-related macular degeneration, with potential for sustained outcomes with a one-time in-office injection.

SEATTLE — Home OCT provides an unprecedented view of fluid recurrence and resolution patterns in individual patients, allowing for prompt, personalized treatment.

Fortifeye Vitamins has released its Next Gen Zinc-Free Macular Defense Formula, a new supplement to target age-related macular degeneration in patients sensitive to zinc.

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended approval of Yesafili, an aflibercept biosimilar, according to a press release from Biocon Biologics.

WASHINGTON — Optometrists, ophthalmologists and retinal specialists surveyed agreed that patients with geographic atrophy should be monitored every 6 months with OCT and fundus autofluorescence, according to Mohammad Rafieetary, OD, FAAO.

WASHINGTON — In this Healio video, Jeffry Gerson, OD, FAAO, shares results from the LIGHTSITE III clinical trial, which evaluated photobiomodulation treatment in patients with dry age-related macular degeneration.

The FDA has given 510(k) clearance to iHealthScreen’s iPredict Eye Screening System, an AI-powered screening tool for age-related macular degeneration in patients aged 50 years and older, according to a company press release.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Steve Charles, MD, dispels the myth that cataract surgery may worsen age-related macular degeneration and diabetic macular edema.